Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1858]

Tepotinib in second line NSCLC treatment

Dr Antonio Passaro and Prof Raffaele Califano

Tepotinib in second line NSCLC treatment ( Dr Antonio Passaro and Prof Raffaele Califano )

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric...

Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer ( Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada )

Consolidation treatment delays do not compromise survival in MRD-negative adult...

Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA

Consolidation treatment delays do not compromise survival in MRD-negative adult ALL ( Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA )

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in...

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )

Tec-Dara significantly improves PFS and OS compared to SoC in relapsed...

Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA

$Tec-Dara significantly improves PFS and OS compared to SoC in relapsed/refractory multiple myeloma ( Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA )$

Black patients show inferior survival despite similar cytogenetics and...

Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine...

Black patients show inferior survival despite similar cytogenetics and treatment response ( Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine, Baltimore, USA )

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and...

Prof Jennifer Woyach - The Ohio State University, Columbus, USA

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and venetoclax-exposed patients ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )

Choosing Wisely: Managing resectable colorectal liver metastases

Dr Christopher Jackson - University of Otago, Otago, New Zeland

Choosing Wisely: Managing resectable colorectal liver metastases ( Dr Christopher Jackson - University of Otago, Otago, New Zeland )

Optimal management of gastric cancers

Dr Prasanth Penumadu - Institution of Cancer Care & Advanced Research...

Optimal management of gastric cancers ( Dr Prasanth Penumadu - Institution of Cancer Care & Advanced Research , Tirupati, India. )

Do all hormone sensitive prostate cancers need triplet therapy?

Dr Deepak Dabkara - Tata Medical Center, Kolkata, India

Do all hormone sensitive prostate cancers need triplet therapy? ( Dr Deepak Dabkara - Tata Medical Center, Kolkata, India )

Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers

Dr Aparna Parikh - Massachusetts General Hospital, Boston, EE.UU

Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers ( Dr Aparna Parikh - Massachusetts General Hospital, Boston, EE.UU )

Tarlatamab improves symptoms and QoL over chemo in previously treated SCLC

Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece

Tarlatamab improves symptoms and QoL over chemo in previously treated SCLC ( Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece )

More from ecancer